Systemic immune index predicts tumor-infiltrating lymphocyte intensity and immunotherapy response in small cell lung cancer

CONCLUSIONS: This study provides a method to investigate the prognostic value of overall immune status by combining the PNI with local immune biomarkers in SCLC. The promising clinical application of PNI in efficacy prediction and beneficiary selection for SCLC immunotherapy is also highlighted.PMID:38496688 | PMC:PMC10938096 | DOI:10.21037/tlcr-23-696

Source: Cell Research - March 18, 2024 Category: Cytology Authors: Chaoqiang Deng Jiatao Liao Zichen Fu Fangqiu Fu Di Li Yuan Li Jialei Wang Haiquan Chen Yang Zhang Source Type: research